Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

NCT02080650 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02080650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02080650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2014
Completion date
July 19, 2016
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced met amplified solid tumor, bladder cancer, colorectal cancer, gastric cancer, non-small cell lung cancer, pancreatic cancer, prostate cancer, renal cell carcinoma